The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksHigh ImpactUpdated•Originally published 25 March 2026•Updated 27 March 2026•

1 min read

NYSE Takes Action Against FiscalNote and BiomX Over Listing Non-Compliance

Golden image with multiple screens displaying financial dashboards, charts, and circuit board designs. Upward arrows, microchips, and peace symbols are also visible.

Key Facts

1The New York Stock Exchange (NYSE) has commenced proceedings to delist FiscalNote Holdings, Inc. (NOTE).

2 months ago

Version History

1 additional source confirmed this story

Version 12 months ago

What changed: The story was updated to include BiomX Inc., which is facing potential delisting risks due to equity deficiencies and auditor warnings about its ability to continue as a going concern.

The New York Stock Exchange (NYSE) has initiated delisting proceedings for FiscalNote Holdings (NOTE), immediately suspending its Class A common stock and warrants. NYSE Regulation determined that FiscalNote no longer meets the suitability standards for continued listing on the exchange. Simultaneously, BiomX Inc. has received a deficiency notification from NYSE American regarding its stockholders' equity levels, which have fallen below required thresholds. The auditor's report for BiomX further highlighted financial risks, including a 'Going Concern' explanatory paragraph regarding its future viability. These developments underscore the heightened regulatory scrutiny on companies failing to maintain minimum financial and market capitalization requirements. Both firms now face potential transitions to over-the-counter (OTC) markets, which typically results in significantly reduced trading liquidity for investors.